Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant

Vox Sanguinis

Volumn 82, Issue 4, 2002, Pages 207-210

  Hoppe, B ^a   Pastucha, L ^b   Seltsam, A ^b   Greinacher, A ^c   Salama, A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Acute haemolytic transfusion reactions; JMH

Indexed keywords

ALLOANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; STANDARD; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; AGED; ANTIBODY FORMATION; CELL CULTURE TECHNIQUES; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYSIS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED;

EID: 0036588974     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00171.x     Document Type: Article

References (16)

1. Rolih SD: High-titer, low-avidity (HTLA) antibodies and antigens: A review. Transfus Med Rev 1989; 3:128-139
2. Salama A, Berghofer H, Mueller Eckhardt C: Detection of cell-drug (hapten)-antibody complexes by the gel test. Transfusion 1992; 32:554-556
3. Nance SJ, Arndt P, Garratty G: Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987; 27:449-452
4. Neppert J, Mueller Eckhardt C: Improved monocyte cytotoxicity test. Immunobiology 1983; 165:415-420
5. Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ: JMH variants: Serologic, clinical, and biochemical analyses in two cases. Transfusion 1995; 35:925-930
6. Issitt PD, Anstee DJ: Applied Blood Group Serology, Edn 4. Durham, North Carolina, USA, Montgomery Scientific Publications, 1998
7. Douglas R, Rowthorne NV, Schneider JV: Some quantitative aspects of the human monocyte erythrophagocytosis and rosette assays. Transfusion 1985; 25:535-539
8. Zupanska B, Thompson E, Brojer E, Merry AH: Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987; 53:96-101
9. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, Edn 10. Oxford, United Kingdom: Blackwell Science Ltd, 1997
10. Patten E, Reddi CR, Riglin H, Edwards J: Delayed hemolytic transfusion reaction caused by a primary immune response. Transfusion 1982; 22:248-250
11. Pineda AA, Taswell HF, Brzica SM: Delayed hemolytic transfusion reaction. An immunologic hazard of blood transfusion. Transfusion 1978; 18:1-7
12. Salama A, Mueller-Eckhardt C: Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogenic and autologous red cells. Transfusion 1984; 24:188-193
13. Molthan L, Matulewicz TJ, Bansal-Carver B, Benz EJ: An immediate hemolytic transfusion reaction due to anti-C and a delayed hemolytic transfusion reaction due to anti-Ce+e: Hemoglobinemia, hemoglobinuria and transient impaired renal function. Vox Sang 1984; 47:348-353
14. Fudenberg H, Allen FH: Transfusion reactions in the absence of demonstrable incompatibility. N Engl J Med 1957; 256:1180-1184
15. Stewart JW, Mollison PL. Rapid destruction of apparently compatible red cells. Br Med J 1959; 1:1274-1275
16. van der Hart M, Engelfriet CP, Prins HK, van Loghem JJ: A haemolytic transfusion reaction without demonstrable antibodies in vitro. Vox Sang 1963; 8:363-370